Skip to main content
. 2017 Mar 31;80(2):169–178. doi: 10.4046/trd.2017.80.2.169

Table 4. The improvement in each question after the education according to the patients' features.

Question* Patients who reported improvement for each question
Q1 Q2 Q3 Q4 Q5 Q6
No. of comorbidities <2 56 (57.1) 38 (38.3) 50 (51.0) 39 (39.8) 39 (39.8) 46 (46.9)
≥2 28 (60.9) 19 (41.3) 33 (71.7) 25 (54.3) 25 (54.3) 17 (37.0)
p-value 0.672 0.772 0.019 0.101 0.101 0.26
Age <60 42 (56.0) 34 (45.3) 43 (57.3) 35 (46.7) 40 (53.3) 39 (52.0)
≥60 42 (60.8) 23 (33.3) 40 (58.0) 29 (42.0) 24 (34.8) 24 (34.7)
p-value 0.554 0.141 0.938 0.576 0.025 0.037
Sex Male 39 (66.1) 28 (47.5) 37 (62.7) 35 (59.3) 29 (49.1) 28 (47.5)
Female 45 (53.0) 29 (34.1) 46 (54.1) 29 (34.1) 35 (41.2) 35 (41.2)
p-value 0.115 0.107 0.305 0.003 0.344 0.455
No. of patients' receiving general asthma education in the past year <3 72 (61.5) 51 (43.6) 73 (62.4) 55 (47.0) 55 (47.0) 52 (44.4)
≥3 12 (44.4) 6 (22.7) 10 (37.0) 9 (33.3) 9 (33.3) 11 (40.7)
p-value 0.104 0.041 0.016 0.197 0.197 0.727
No. of patients who were taught how to use their inhaler(s) in the past year <3 67 (62.6) 45 (42.0) 68 (63.6) 52 (48.6) 53 (49.5) 52 (48.6)
≥3 17 (45.9) 12 (32.4) 15 (40.5) 12 (32.4) 11 (29.7) 11 (29.7)
p-value 0.076 0.302 0.015 0.088 0.037 0.046

Values are presented as number (%).

*Q1: I know asthma well; Q2: Asthma needs to be treated continuously; Q3: I know what to do if my respiratory symptoms become aggravated; Q4: Inhalers are the most important for controlling asthma; Q5: I know how to use my inhaler(s) well; Q6: I use my inhaler(s) regularly according to my physician's prescription.